338 related articles for article (PubMed ID: 15370706)
21. Antiphospholipid antibodies and anetoderma: are they associated?
Stephansson EA; Niemi KM
Dermatology; 1995; 191(3):204-9. PubMed ID: 8534938
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
[TBL] [Abstract][Full Text] [Related]
23. Lupus erythematosus profundus: a cutaneous marker for a distinct clinical subset?
Watanabe T; Tsuchida T
Br J Dermatol; 1996 Jan; 134(1):123-5. PubMed ID: 8745897
[TBL] [Abstract][Full Text] [Related]
24. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
Shoenfeld Y; Meroni PL; Toubi E
Curr Opin Rheumatol; 2009 Sep; 21(5):495-500. PubMed ID: 19593144
[TBL] [Abstract][Full Text] [Related]
25. Lupus erythematosus panniculitis: clinicopathological, immunophenotypic, and molecular studies.
Park HS; Choi JW; Kim BK; Cho KH
Am J Dermatopathol; 2010 Feb; 32(1):24-30. PubMed ID: 20098081
[TBL] [Abstract][Full Text] [Related]
26. Lupus erythematosus panniculitis.
Fraga J; García-Díez A
Dermatol Clin; 2008 Oct; 26(4):453-63, vi. PubMed ID: 18793977
[TBL] [Abstract][Full Text] [Related]
27. [Cutaneous lupus profundus].
Khalfallah N; Azzabi S; Ben Hassine L; Fathallah L; Kooli C; Fazâa B; Hamza M; Haddad A
Tunis Med; 2003 Feb; 81(2):134-9. PubMed ID: 12708181
[TBL] [Abstract][Full Text] [Related]
28. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
29. Anetoderma secondary to antiphospholipid antibodies.
Eungdamrong J; Fischer M; Patel R; Meehan S; Sanchez M
Dermatol Online J; 2012 Dec; 18(12):26. PubMed ID: 23286816
[TBL] [Abstract][Full Text] [Related]
30. Anetoderma accompanying microscopic panniculitis in a patient with antiphospholipid syndrome and systemic lupus erythematosus.
Funabiki M; Tanioka M; Miyachi Y; Utani A
Clin Exp Dermatol; 2009 Mar; 34(2):259-61. PubMed ID: 19187309
[No Abstract] [Full Text] [Related]
31. Systemic sclerosis with unusual panniculitis and overlying discoid lupus erythematosus-like lesions.
Oka H; Tanikawa A; Matsuda F; Tanaka M; Nishikawa T
J Dtsch Dermatol Ges; 2005 Aug; 3(8):627-9. PubMed ID: 16033482
[TBL] [Abstract][Full Text] [Related]
32. Lupus erythematosus panniculitis in children: report of three cases and review of previously reported cases.
Weingartner JS; Zedek DC; Burkhart CN; Morrell DS
Pediatr Dermatol; 2012; 29(2):169-76. PubMed ID: 22066977
[TBL] [Abstract][Full Text] [Related]
33. The prevalence of antiphospholipid antibody syndrome among systemic lupus erythematosus patients.
McMahon MA; Keogan M; O'Connell P; Kearns G
Ir Med J; 2006; 99(10):296-8. PubMed ID: 17274170
[TBL] [Abstract][Full Text] [Related]
34. Anetoderma before development of antiphospholipid antibodies: delayed development and monitoring of antiphospholipid antibodies in an SLE patient presenting with anetoderma.
Xia FD; Hoang MP; Smith GP
Dermatol Online J; 2017 Mar; 23(3):. PubMed ID: 28329518
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous manifestations of lupus erythematosus.
Laman SD; Provost TT
Rheum Dis Clin North Am; 1994 Feb; 20(1):195-212. PubMed ID: 8153399
[TBL] [Abstract][Full Text] [Related]
36. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
37. What is lupus? What is not lupus?
Panush RS; Greer JM; Morshedian KK
Rheum Dis Clin North Am; 1993 Feb; 19(1):223-34. PubMed ID: 8356256
[TBL] [Abstract][Full Text] [Related]
38. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
Serikova SIu; Kozlovskaia NL; Shilov EM
Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
[TBL] [Abstract][Full Text] [Related]
39. Panniculitis in childhood-onset systemic lupus erythematosus: a multicentric cohort study.
Verdier M; Anuardo P; Gormezano NWS; Romiti R; Campos LMA; Aikawa NE; Pereira RMR; Terreri MT; Magalhães CS; Ferreira JCOA; Silva MFC; Ferriani M; Sakamoto AP; Ferriani VPL; Centeville M; Sato J; Santos MC; Bonfá E; Silva CA
Adv Rheumatol; 2019 Jan; 59(1):3. PubMed ID: 30658703
[TBL] [Abstract][Full Text] [Related]
40. Systemic lupus erythematosus-associated anetoderma and anti-phospholipid antibodies.
Fernández-Galar M; España A; Lloret P
Clin Exp Dermatol; 2003 Jan; 28(1):39-42. PubMed ID: 12558628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
